Skip to main content
Orum Therapeutics, Inc. logo

Orum Therapeutics, Inc. — Investor Relations & Filings

Ticker · 475830 ISIN · KR7475830006 KO Professional, scientific and technical activities
Open in API
Filings indexed 84 across all filing types
Latest filing 2025-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 475830

About Orum Therapeutics, Inc.

https://www.orumrx.com/

Orum Therapeutics is a clinical-stage biotechnology company that develops targeted protein degradation (TPD) therapeutics. The company's proprietary TPD²® platform creates a novel class of antibody-drug conjugates (ADCs), referred to as degrader-antibody conjugates (DACs). This technology combines the cell-targeting precision of antibodies with the catalytic action of protein degraders. The approach is designed to selectively deliver payloads to diseased cells to eliminate intracellular proteins that are difficult to target with conventional drugs. Orum's primary focus is on developing treatments for cancer, aiming to improve efficacy and safety over existing therapies.

Recent filings

Filing Released Lang Actions
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for Orum Therapeutics, Inc. (오름테라퓨틱 주식회사) covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial information, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 100% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, purpose (participation in a conference), and method of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it is a regulatory disclosure of an event schedule, it fits the 'Regulatory Filings' (RNS) category as a general corporate announcement.
2025-05-13 Korean
투자판단관련주요경영사항(임상시험계획자진취하등)
Legal Proceedings Report Classification · 100% confidence The document is a formal regulatory disclosure from OREUM Therapeutics regarding the voluntary discontinuation of a Phase 1 clinical trial (ORM-5029). It details the clinical trial status, the reason for discontinuation (strategic resource allocation and risk-benefit profile), and the impact on the company's pipeline. This falls under the category of significant corporate developments related to regulatory and operational matters, which is best classified as a Regulatory Filing (RNS) as it does not fit into specific categories like M&A or financial reports.
2025-04-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under Article 147 of the Capital Markets Act. It details changes in share ownership by a major shareholder (the CEO, Lee Sung-joo) and special related parties. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-04-18 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a mandatory regulatory filing in South Korea under the Capital Markets Act. This document details changes in share ownership by major shareholders and special related parties, including the purpose of holding (influence on management). This falls under the 'Major Shareholding Notification' category.
2025-04-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the resolutions passed during the meeting held on March 28, 2025, including financial statement approval, director/auditor compensation limits, and board composition. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2025-03-28 Korean

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.